Coronary artery disease trials in Netherlands
69 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleVascular Events In Patients Undergoing Same-day Noncardiac Surgery (VALIANCE) Study
- Where
- Rotterdam
- Age
- 45 years and over
- People
- 15,000 worldwide
- Run by
- Centre hospitalier de l'Université de Montréal (CHUM)
See details and how to joinNCT04973397 - Phase 3Taking peopleA Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.
- Where
- Enschede, Nijmegen
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- EBI Anti Sepsis BV
See details and how to joinNCT07357675 - No phaseNot yet taking people in NetherlandsThe CORE Platform Trial
- Where
- Utrecht
- Age
- 18 years and over
- People
- 15,000 worldwide
- Run by
- Copenhagen Trial Unit, Center for Clinical Intervention Research
See details and how to joinNCT07892976 - No phaseTaking peopleProduct Surveillance Registry
- Where
- Amsterdam, Doetinchem, Eindhoven, Enschede, Groningen, Hengelo, Leiden, Maastricht, Nieuwegein, Rotterdam, The Hague
- People
- 100,000 worldwide
- Run by
- Medtronic
See details and how to joinNCT01524276 - No phaseTaking peopleThe Multicenter Cardiology Monitoring Platform Registry
- Where
- Maastricht
- Age
- 16 years and over
- People
- 40,000
- Run by
- Maastricht University Medical Center
See details and how to joinNCT04976348 - Phase 4Not yet taking people in NetherlandsSpontaneous Coronary Artery Dissection - AntipLatelet Therapy Intensity in Guided coNservative Management (SCAD-ALIGN) Trial
- Where
- Nieuwegein
- Age
- 18 years and over
- People
- 3,518 worldwide
- Run by
- Universitätsklinikum Hamburg-Eppendorf
See details and how to joinNCT07683923 · EU 2025-523985-26-00 - No phaseTaking peopleAbbott Vascular Medical Device Registry
- Where
- Nieuwegein
- Age
- 18 years and over
- People
- 3,784 worldwide
- Run by
- Abbott Medical Devices
See details and how to joinNCT04573660 - No phaseTaking peopleAnalysis of Life-threatening ARrhythMias After Acute Coronary Syndrome
- Where
- Eindhoven
- Age
- 18 years and over
- People
- 2,775
- Run by
- Catharina Ziekenhuis Eindhoven
See details and how to joinNCT07824050 - Phase 3Taking peopleLow Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- Where
- Deventer, Doetinchem, Gouda, Groningen, Leiderdorp, Maastricht, Tilburg, Utrecht
- Age
- 18 years and over
- People
- 6,150 worldwide
- Run by
- Population Health Research Institute
See details and how to joinNCT04774159 - No phaseTaking peopleDEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy.
- Where
- Leiden
- Age
- 18 years and over
- People
- 128 worldwide
- Run by
- Fundación EPIC
See details and how to joinNCT06657833 - Phase 2/3Taking peopleCombined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- Where
- Apeldoorn, Eindhoven, Rotterdam
- Age
- 18 years and over
- People
- 3,110 worldwide
- Run by
- CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00 - Phase 1/2Taking peopleA Phase 1b/2a Trial to Evaluate Invobenitug Also Known as Procizumab (PCZ; AK1967) in Critical Cardiovascular Care.
- Where
- Nijmegen
- Age
- 18 years to 80 years
- People
- 90 worldwide
- Run by
- 4TEEN4 Pharmaceuticals GmbH
See details and how to joinNCT06832722 · EU 2024-518450-16-00 - No phaseTaking peoplePre Hospital Triage of Patients at Intermediate and High Risk for ACS
- Where
- Haps, Nijmegen
- Age
- 18 years and over
- People
- 1,048
- Run by
- Cyril Camaro
See details and how to joinNCT07252245 - Phase 2Taking peopleAn investigational trial to evaluate the effects of the drug XC001 delivered via a catheter in subjects with chronic angina caused by coronary artery disease (EXACT-2 Trial)
- Where
- Amersfoort, Amsterdam, Hilversum, Leiden, Rotterdam, Utrecht
- Age
- 18 years and over
- People
- 84 worldwide
- Run by
- Xylocor Therapeutics Inc.
See details and how to join2024-514874-36-01 · EU 2024-514874-36-01 - No phaseTaking peopleMultivessel Minimally Invasive Coronary Bypass Grafting as HYBRID Revascularization Versus Conventional Off-pump Coronary Artery Bypass Grafting
- Where
- Eindhoven
- Age
- 18 years to 85 years
- People
- 250 worldwide
- Run by
- Catharina Ziekenhuis Eindhoven
See details and how to joinNCT07314138 - No phaseTaking peopleRandomization of Single vs Multiple Arterial Grafts
- Where
- Maastricht
- Age
- 18 years to 70 years
- People
- 4,300 worldwide
- Run by
- Weill Medical College of Cornell University
See details and how to joinNCT03217006 - No phaseTaking peopleCardiovascular-kidney-metabolic (CKM)-Guided Therapy for Patients After Acute Coronary Syndrome
- Where
- Heerlen
- Age
- 18 years and over
- People
- 1,215
- Run by
- Zuyderland Medisch Centrum
See details and how to joinNCT07773272 - No phaseTaking peopleVegetarian Diet and Innate Immunity in Patients With Myocardial Infarction and in Healthy Volunteers (FRESH-MI Study)
- Where
- Nijmegen
- Age
- 18 years and over
- People
- 120
- Run by
- Radboud University Medical Center
See details and how to joinNCT06209723 - Phase 3Taking peopleA Phase III Prospective, Multicenter, Open-label Study to Assess Diagnostic Efficacy of a Novel 18F-labelled Tracer, SYN2, for Positron Emission Tomography in Subjects with Suspected Coronary Artery Disease
- Where
- Amsterdam, Breda, Groningen, Rotterdam
- Age
- 18 years and over
- People
- 290 worldwide
- Run by
- Syn2bio S.A.
See details and how to join2023-506971-89-00 · EU 2023-506971-89-00 - No phaseEnrolling by invitationMeasuring Athlete's Risk of Cardiovascular Events 3 (MARC-3)
- Where
- Nijmegen, Utrecht
- Age
- 45 years and over
- People
- 250
- Run by
- Radboud University Medical Center
See details and how to joinNCT07625488 - No phaseNot yet taking people in NetherlandsA Physical Activity Programme Focussed on Step Volume and Intensity for People With Cardiovascular Disease: Getting Active and Staying Active After Cardiac Rehabilitation
- Where
- Arnhem, Nijmegen, Uden
- Age
- 18 years and over
- People
- 334
- Run by
- Radboud University Medical Center
See details and how to joinNCT07723274 - No phaseTaking peopleRevascularization Versus Optimal Medical Therapy of Chronic Total Coronary Occlusions on Left Ventricular Ischemia Reduction
- Where
- Amsterdam
- Age
- 18 years and over
- People
- 48
- Run by
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
See details and how to joinNCT03756870 - Phase 4Taking peopleComparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients
- Where
- Breda, Dordrecht, Eindhoven, Nijmegen, Rotterdam, The Hague
- People
- 1,656 worldwide
- Run by
- Research Maatschap Cardiologen Rotterdam Zuid
See details and how to joinNCT05491200 - Phase 3Taking peopleAn International, Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Trial on the Effects of EA-230 on the Length of Hospital Stay Following On-Pump Coronary Artery Bypass Grafting Surgery
- Where
- Enschede, Nijmegen
- Age
- 18 years and over
- People
- 150 worldwide
- Run by
- EBI Anti Sepsis B.V.
See details and how to join2025-525053-39-00 · EU 2025-525053-39-00 - No phaseNot yet taking people in NetherlandsThe HYCORE1 Trial: Hybrid Revascularization Versus Coronary Artery Bypass Grafting
- Where
- Utrecht
- Age
- 18 years to 80 years
- People
- 1,048 worldwide
- Run by
- Copenhagen University Hospital, Rigshospitalet
See details and how to joinNCT05504031